Evidence map›Paper›PMID 30214018›Full record

ArticleScientific reports2018

Groucho related gene 5 (GRG5) is involved in embryonic and neural stem cell state decisions.

Konstantina Chanoumidou, Christiana Hadjimichael, Paraskevi Athanasouli, Henrik Ahlenius, Antonis Klonizakis, Christoforos Nikolaou, Elias Drakos, Antonis Kostouros, Irene Stratidaki, Maria Grigoriou and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Konstantina ChanoumidouDepartment of Molecular Biology and Genetics, Democritus University of Thrace, 68100, Alexandroupoli, Greece.
Christiana HadjimichaelInstitute of Molecular Biology and Biotechnology, Foundation for Research and Technology-Hellas (FORTH), 70013, Heraklion, Crete, Greece.
Paraskevi AthanasouliInstitute of Molecular Biology and Biotechnology, Foundation for Research and Technology-Hellas (FORTH), 70013, Heraklion, Crete, Greece.
Henrik AhleniusLund Stem Cell Center, University Hospital, SE-221 84, Lund, Sweden.ORCID 0000-0001-8958-6148
Antonis KlonizakisDepartment of Biology, University of Crete, 71409, Heraklion, Crete, Greece.
Christoforos NikolaouDepartment of Biology, University of Crete, 71409, Heraklion, Crete, Greece.
Elias DrakosSchool of Medicine, University of Crete, 71003, Heraklion, Crete, Greece.
Antonis KostourosSchool of Medicine, University of Crete, 71003, Heraklion, Crete, Greece.
Irene StratidakiInstitute of Molecular Biology and Biotechnology, Foundation for Research and Technology-Hellas (FORTH), 70013, Heraklion, Crete, Greece.
Maria GrigoriouDepartment of Molecular Biology and Genetics, Democritus University of Thrace, 68100, Alexandroupoli, Greece.
Androniki KretsovaliInstitute of Molecular Biology and Biotechnology, Foundation for Research and Technology-Hellas (FORTH), 70013, Heraklion, Crete, Greece. kretsova@imbb.forth.gr.ORCID 0000-0003-2949-1619
University of Crete · GRDemocritus University of Thrace · GRFoundation for Research and Technology Hellas · GRFORTH Institute of Molecular Biology and Biotechnology · GRLund University · SE

Funding

General Secretariat for Research and Technology (GSRT) 11SYN_10_668
6 · The paper itself

Abstract

Groucho related gene 5 (GRG5) is a multifunctional protein that has been implicated in late embryonic and postnatal mouse development. Here, we describe a previously unknown role of GRG5 in early developmental stages by analyzing its function in stem cell fate decisions. By both loss and gain of function approaches we demonstrate that ablation of GRG5 deregulates the Embryonic Stem Cell (ESC) pluripotent state whereas its overexpression leads to enhanced self-renewal and acquisition of cancer cell-like properties. The malignant characteristics of teratomas generated by ESCs that overexpress GRG5 reveal its pro-oncogenic potential. Furthermore, transcriptomic analysis and cell differentiation approaches underline GRG5 as a multifaceted signaling regulator that represses mesendodermal-related genes. When ESCs exit pluripotency, GRG5 promotes neuroectodermal specification via Wnt and BMP signaling suppression. Moreover, GRG5 promotes the neuronal reprogramming of fibroblasts and maintains the self-renewal of Neural Stem Cells (NSCs) by sustaining the activity of Notch/Hes and Stat3 signaling pathways. In summary, our results demonstrate that GRG5 has pleiotropic roles in stem cell biology functioning as a stemness factor and a neural fate specifier.

Indexed as

AnimalsCell DifferentiationCell ProliferationCells, CulturedCell Transformation, NeoplasticCo-Repressor ProteinsEmbryonic Stem CellsGene Expression ProfilingGene Expression Regulation, DevelopmentalMiceNeural PlateNeural Stem CellsPluripotent Stem CellsRNA InterferenceRNA, Small InterferingTranscription FactorsCo-Repressor ProteinsRNA, Small InterferingTle5 protein, mouseTranscription Factors

Identifiers

PMID30214018
PMCPMC6137157
OpenAlexW2891681059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.